Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats

Junesun Kim, Jung Hoon Kim, Youngkyung Kim, Hwi young Cho, Seung Kil Hong, Young Wook Yoon

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)


In the present study we determined whether spinal cholecystokinin (CCK) or the cholecystokinin receptor is involved in below-level neuropathic pain of spinal cord injury (SCI). The effect of the CCKB receptor antagonist, CI-988 on mechanical allodynia and the expression level of CCK and CCKB receptor were investigated. Spinal hemisection was done at the T13 level in rats under enflurane anesthesia. CI-988 was administered intraperitoneally and intrathecally and behavioral tests were conducted. After systemic injection, mechanical allodynia was reduced by higher doses of CI-988 (10 and 20 mg/kg). Intrathecal CI-988 (100, 200 and 500 μg) dose-dependently increased the paw withdrawal threshold in both paws. Following spinal hemisection, CCK mRNA expression increased on the ipsilateral side at the spinal segments caudal to the injury and both sides of the spinal L4-5 segments without any significant changes in CCKB receptor mRNA levels. These results suggest that up-regulation of spinal CCK may contribute to maintenance of mechanical allodynia following SCI and that clinical application of CI-988 or similar drugs may be useful therapeutic agents for management of central neuropathic pain.

Original languageEnglish
Pages (from-to)303-307
Number of pages5
JournalNeuroscience Letters
Issue number3
Publication statusPublished - 2009 Sep 25


  • Allodynia
  • CI-988
  • Central pain
  • Cholecystokinin
  • Neuropathic pain
  • Spinal cord injury

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats'. Together they form a unique fingerprint.

Cite this